{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,22]],"date-time":"2026-01-22T14:04:52Z","timestamp":1769090692818,"version":"3.49.0"},"reference-count":49,"publisher":"Oxford University Press (OUP)","issue":"7","license":[{"start":{"date-parts":[[2011,4,1]],"date-time":"2011-04-01T00:00:00Z","timestamp":1301616000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/academic.oup.com\/pages\/standard-publication-reuse-rights"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2011,4,1]]},"abstract":"<jats:title>Abstract<\/jats:title>\n               <jats:p>Older adults exhibit higher morbidity and mortality from infectious diseases compared with those of the general population. The introduction and rapid spread of West Nile virus (WNV) throughout the continental United States since 1999 has highlighted the challenge of protecting older adults against emerging pathogens: to this day there is no therapy or vaccine approved for human use against West Nile encephalitis. In this study, we describe the characterization of T and B cell responses in old mice after vaccination with RepliVAX WN, a novel West Nile encephalitis vaccine based on single-cycle flavivirus particles. In adult mice, RepliVAX WN induced robust and long-lasting CD4+ and CD8+ T cell and Ab (B cell) responses against natural WNV epitopes, similar to those elicited by primary WNV infection. Primary and memory T and B cell responses in old mice against RepliVAX WN vaccination were significantly lower than those seen in younger mice, similar to the response of old mice to infection with WNV. Surprisingly, both the quality and the quantity of the recall Ab and T cell responses in vaccinated old mice were improved to equal or exceed those in adult animals. Moreover, these responses together (but not individually) were sufficient to protect both old and adult mice from severe WNV disease upon challenge. Therefore, at least two cycles of in vivo restimulation are needed for selection and expansion of protective lymphocytes in older populations, and live, single-cycle virus vaccines that stimulate both cellular and humoral immunity can protect older individuals against severe viral disease.<\/jats:p>","DOI":"10.4049\/jimmunol.1002799","type":"journal-article","created":{"date-parts":[[2011,2,22]],"date-time":"2011-02-22T03:08:51Z","timestamp":1298344131000},"page":"3882-3891","source":"Crossref","is-referenced-by-count":37,"title":["Repeated In Vivo Stimulation of T and B Cell Responses in Old Mice Generates Protective Immunity against Lethal West Nile Virus Encephalitis"],"prefix":"10.1093","volume":"186","author":[{"given":"Jennifer L","family":"Uhrlaub","sequence":"first","affiliation":[{"name":"Department of Immunobiology, College of Medicine, University of Arizona , Tucson, AZ 85719"},{"name":"Arizona Center on Aging, College of Medicine, University of Arizona , Tucson, AZ 85719"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"James D","family":"Brien","sequence":"additional","affiliation":[{"name":"Department of Microbiology, Washington University , St. Louis, MO 63110"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Douglas G","family":"Widman","sequence":"additional","affiliation":[{"name":"Department of Microbiology and Immunology, University of Texas Medical Branch , Galveston, TX 77555"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Peter W","family":"Mason","sequence":"additional","affiliation":[{"name":"Department of Pathology, University of Texas Medical Branch , Galveston, TX 77555"},{"name":"Sealy Center for Vaccine Development, University of Texas Medical Branch , Galveston, TX 77555"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Janko","family":"Nikolich-\u017dugich","sequence":"additional","affiliation":[{"name":"Department of Immunobiology, College of Medicine, University of Arizona , Tucson, AZ 85719"},{"name":"Arizona Center on Aging, College of Medicine, University of Arizona , Tucson, AZ 85719"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"286","published-online":{"date-parts":[[2011,4,1]]},"reference":[{"key":"2025032411163649500_r1","doi-asserted-by":"crossref","first-page":"413","DOI":"10.1086\/313737","article-title":"The West Nile Virus outbreak of 1999 in New York: the Flushing Hospital experience","volume":"30","author":"Asnis","year":"2000","journal-title":"Clin. Infect. Dis."},{"key":"2025032411163649500_r2","doi-asserted-by":"crossref","first-page":"1174","DOI":"10.3201\/eid1108.050289b","article-title":"Virology, pathology, and clinical manifestations of West Nile virus disease","volume":"11","author":"Hayes","year":"2005","journal-title":"Emerg. Infect. Dis."},{"key":"2025032411163649500_r3","doi-asserted-by":"crossref","first-page":"1325","DOI":"10.1017\/S0950268806006339","article-title":"Risk factors for encephalitis and death from West Nile virus infection","volume":"134","author":"Murray","year":"2006","journal-title":"Epidemiol. Infect."},{"key":"2025032411163649500_r4","doi-asserted-by":"crossref","first-page":"5233","DOI":"10.1016\/j.vaccine.2007.05.034","article-title":"WHO informal consultation on the scientific basis of specifications for production and control of inactivated Japanese encephalitis vaccines for human use, Geneva, Switzerland, 1-2 June 2006","volume":"25","author":"Ferguson","year":"2007","journal-title":"Vaccine"},{"key":"2025032411163649500_r5","doi-asserted-by":"crossref","first-page":"850","DOI":"10.1086\/511869","article-title":"Yellow fever: epidemiology and prevention","volume":"44","author":"Barnett","year":"2007","journal-title":"Clin. Infect. Dis."},{"key":"2025032411163649500_r6","doi-asserted-by":"crossref","first-page":"1727","DOI":"10.1016\/j.vaccine.2006.11.027","article-title":"Neurologic disease associated with 17D-204 yellow fever vaccination: a report of 15 cases","volume":"25","author":"McMahon","year":"2007","journal-title":"Vaccine"},{"key":"2025032411163649500_r7","doi-asserted-by":"crossref","first-page":"3827","DOI":"10.1016\/j.vaccine.2010.03.023","article-title":"Inactivated yellow fever 17D vaccine: development and nonclinical safety, immunogenicity and protective activity","volume":"28","author":"Monath","year":"2010","journal-title":"Vaccine"},{"key":"2025032411163649500_r8","doi-asserted-by":"crossref","first-page":"261","DOI":"10.1016\/S0140-6736(01)05480-0","article-title":"Epidemic West Nile encephalitis, New York, 1999: results of a household-based seroepidemiological survey","volume":"358","author":"Mostashari","year":"2001","journal-title":"Lancet"},{"key":"2025032411163649500_r9","doi-asserted-by":"crossref","first-page":"173","DOI":"10.7326\/0003-4819-137-3-200208060-00009","article-title":"West Nile virus: a primer for the clinician","volume":"137","author":"Petersen","year":"2002","journal-title":"Ann. Intern. Med."},{"key":"2025032411163649500_r10","doi-asserted-by":"crossref","first-page":"654","DOI":"10.3201\/eid0704.017409","article-title":"Clinical findings of West Nile virus infection in hospitalized patients, New York and New Jersey, 2000","volume":"7","author":"Weiss","year":"2001","journal-title":"Emerg. Infect. Dis."},{"key":"2025032411163649500_r11","doi-asserted-by":"crossref","first-page":"1807","DOI":"10.1056\/NEJM200106143442401","article-title":"The outbreak of West Nile virus infection in the New York City area in 1999","volume":"344","author":"Nash","year":"2001","journal-title":"N. Engl. J. Med."},{"key":"2025032411163649500_r12","doi-asserted-by":"crossref","first-page":"1617","DOI":"10.1086\/518281","article-title":"The long-term outcomes of human West Nile virus infection","volume":"44","author":"Sejvar","year":"2007","journal-title":"Clin. Infect. Dis."},{"key":"2025032411163649500_r13","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1111\/j.0105-2896.2005.00276.x","article-title":"Immunosenescence: a problem of lymphopoiesis, homeostasis, microenvironment, and signaling","volume":"205","author":"Cambier","year":"2005","journal-title":"Immunol. Rev."},{"key":"2025032411163649500_r14","doi-asserted-by":"crossref","first-page":"512","DOI":"10.1038\/nri2318","article-title":"Ageing and life-long maintenance of T-cell subsets in the face of latent persistent infections","volume":"8","author":"Nikolich-\u017dugich","year":"2008","journal-title":"Nat. Rev. Immunol."},{"key":"2025032411163649500_r15","doi-asserted-by":"crossref","first-page":"480","DOI":"10.1016\/j.coi.2005.07.019","article-title":"Memory T cell homeostasis and senescence during aging","volume":"17","author":"Akbar","year":"2005","journal-title":"Curr. Opin. Immunol."},{"key":"2025032411163649500_r16","doi-asserted-by":"crossref","first-page":"406","DOI":"10.1016\/j.it.2004.05.006","article-title":"Is immunosenescence infectious?","volume":"25","author":"Pawelec","year":"2004","journal-title":"Trends Immunol."},{"key":"2025032411163649500_r17","doi-asserted-by":"crossref","first-page":"70","DOI":"10.1126\/science.273.5271.70","article-title":"The aging immune system: primer and prospectus","volume":"273","author":"Miller","year":"1996","journal-title":"Science"},{"key":"2025032411163649500_r18","doi-asserted-by":"crossref","first-page":"M627","DOI":"10.1093\/gerona\/57.10.M627","article-title":"Influenza: a preventable lethal disease","volume":"57","author":"McElhaney","year":"2002","journal-title":"J. Gerontol. A Biol. Sci. Med. Sci."},{"key":"2025032411163649500_r19","doi-asserted-by":"crossref","first-page":"2762","DOI":"10.1016\/j.vaccine.2008.03.009","article-title":"Construction and characterization of a second-generation pseudoinfectious West Nile virus vaccine propagated using a new cultivation system","volume":"26","author":"Widman","year":"2008","journal-title":"Vaccine"},{"key":"2025032411163649500_r20","doi-asserted-by":"crossref","first-page":"1855","DOI":"10.1002\/eji.200737196","article-title":"Protective capacity and epitope specificity of CD8(+) T cells responding to lethal West Nile virus infection","volume":"37","author":"Brien","year":"2007","journal-title":"Eur. J. Immunol."},{"key":"2025032411163649500_r21","doi-asserted-by":"crossref","first-page":"8568","DOI":"10.4049\/jimmunol.181.12.8568","article-title":"West Nile virus-specific CD4 T cells exhibit direct antiviral cytokine secretion and cytotoxicity and are sufficient for antiviral protection","volume":"181","author":"Brien","year":"2008","journal-title":"J. Immunol."},{"key":"2025032411163649500_r22","doi-asserted-by":"crossref","first-page":"371","DOI":"10.1146\/annurev.micro.56.012302.160654","article-title":"The molecular biology of West Nile Virus: a new invader of the western hemisphere","volume":"56","author":"Brinton","year":"2002","journal-title":"Annu. Rev. Microbiol."},{"key":"2025032411163649500_r23","doi-asserted-by":"crossref","first-page":"519","DOI":"10.1016\/S1473-3099(02)00368-7","article-title":"West Nile virus","volume":"2","author":"Campbell","year":"2002","journal-title":"Lancet Infect. Dis."},{"key":"2025032411163649500_r24","doi-asserted-by":"crossref","first-page":"5563","DOI":"10.1016\/j.vaccine.2006.12.005","article-title":"West Nile virus: recent trends in diagnosis and vaccine development","volume":"25","author":"Dauphin","year":"2007","journal-title":"Vaccine"},{"key":"2025032411163649500_r25","doi-asserted-by":"crossref","first-page":"196","DOI":"10.1016\/j.virol.2006.02.036","article-title":"Evaluation of replicative capacity and genetic stability of West Nile virus replicons using highly efficient packaging cell lines","volume":"351","author":"Fayzulin","year":"2006","journal-title":"Virology"},{"key":"2025032411163649500_r26","doi-asserted-by":"crossref","first-page":"294","DOI":"10.1016\/0042-6822(91)90034-9","article-title":"Japanese encephalitis virus-vaccinia recombinants produce particulate forms of the structural membrane proteins and induce high levels of protection against lethal JEV infection","volume":"180","author":"Mason","year":"1991","journal-title":"Virology"},{"key":"2025032411163649500_r27","doi-asserted-by":"crossref","first-page":"5550","DOI":"10.1016\/j.vaccine.2009.07.016","article-title":"RepliVAX WN, a single-cycle flavivirus vaccine to prevent West Nile disease, elicits durable protective immunity in hamsters","volume":"27","author":"Widman","year":"2009","journal-title":"Vaccine"},{"key":"2025032411163649500_r28","doi-asserted-by":"crossref","first-page":"1160","DOI":"10.4269\/ajtmh.2010.09-0310","article-title":"Evaluation of RepliVAX WN, a single-cycle flavivirus vaccine, in a non-human primate model of West Nile virus infection","volume":"82","author":"Widman","year":"2010","journal-title":"Am. J. Trop. Med. Hyg."},{"key":"2025032411163649500_r29","doi-asserted-by":"crossref","first-page":"9100","DOI":"10.1128\/JVI.00316-07","article-title":"Early production of type I interferon during West Nile virus infection: role for lymphoid tissues in IRF3-independent interferon production","volume":"81","author":"Bourne","year":"2007","journal-title":"J. Virol."},{"key":"2025032411163649500_r30","doi-asserted-by":"crossref","first-page":"1845","DOI":"10.1002\/eji.200737192","article-title":"Antigen-specific cytotoxic T lymphocytes protect against lethal West Nile virus encephalitis","volume":"37","author":"Purtha","year":"2007","journal-title":"Eur. J. Immunol."},{"key":"2025032411163649500_r31","doi-asserted-by":"crossref","first-page":"14374","DOI":"10.1073\/pnas.0506250102","article-title":"Innate signals compensate for the absence of PKC-theta during in vivo CD8(+) T cell effector and memory responses","volume":"102","author":"Marsland","year":"2005","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"2025032411163649500_r32","doi-asserted-by":"crossref","first-page":"1191","DOI":"10.1038\/ni1009","article-title":"Selective expression of the interleukin 7 receptor identifies effector CD8 T cells that give rise to long-lived memory cells","volume":"4","author":"Kaech","year":"2003","journal-title":"Nat. Immunol."},{"key":"2025032411163649500_r33","doi-asserted-by":"crossref","first-page":"2735","DOI":"10.1084\/jem.20090222","article-title":"Key role of T cell defects in age-related vulnerability to West Nile virus","volume":"206","author":"Brien","year":"2009","journal-title":"J. Exp. Med."},{"key":"2025032411163649500_r34","doi-asserted-by":"crossref","first-page":"1347","DOI":"10.1084\/jem.20040437","article-title":"Age-related CD8 T cell clonal expansions constrict CD8 T cell repertoire and have the potential to impair immune defense","volume":"200","author":"Messaoudi","year":"2004","journal-title":"J. Exp. Med."},{"key":"2025032411163649500_r35","doi-asserted-by":"crossref","first-page":"12149","DOI":"10.1128\/JVI.01732-06","article-title":"Antibody recognition and neutralization determinants on domains I and II of West Nile Virus envelope protein","volume":"80","author":"Oliphant","year":"2006","journal-title":"J. Virol."},{"key":"2025032411163649500_r36","doi-asserted-by":"crossref","first-page":"885","DOI":"10.1517\/14712598.7.6.885","article-title":"The molecular basis of antibody-mediated neutralization of West Nile virus","volume":"7","author":"Oliphant","year":"2007","journal-title":"Expert Opin. Biol. Ther."},{"key":"2025032411163649500_r37","doi-asserted-by":"crossref","first-page":"2805","DOI":"10.4049\/jimmunol.135.4.2805","article-title":"Protection against 17D yellow fever encephalitis in mice by passive transfer of monoclonal antibodies to the nonstructural glycoprotein gp48 and by active immunization with gp48","volume":"135","author":"Schlesinger","year":"1985","journal-title":"J. Immunol."},{"key":"2025032411163649500_r38","doi-asserted-by":"crossref","first-page":"290","DOI":"10.1016\/0042-6822(92)90317-I","article-title":"Recombinant vaccinia virus producing the prM and E proteins of yellow fever virus protects mice from lethal yellow fever encephalitis","volume":"187","author":"Pincus","year":"1992","journal-title":"Virology"},{"key":"2025032411163649500_r39","doi-asserted-by":"crossref","first-page":"1340","DOI":"10.1128\/JVI.80.3.1340-1351.2006","article-title":"Antibodies against West Nile Virus nonstructural protein NS1 prevent lethal infection through Fc gamma receptor-dependent and -independent mechanisms","volume":"80","author":"Chung","year":"2006","journal-title":"J. Virol."},{"key":"2025032411163649500_r40","doi-asserted-by":"crossref","first-page":"325","DOI":"10.1111\/j.1749-6632.2001.tb02708.x","article-title":"West Nile virus envelope protein: role in diagnosis and immunity","volume":"951","author":"Wang","year":"2001","journal-title":"Ann. N. Y. Acad. Sci."},{"key":"2025032411163649500_r41","doi-asserted-by":"crossref","first-page":"4040","DOI":"10.1128\/JVI.75.9.4040-4047.2001","article-title":"West Nile virus recombinant DNA vaccine protects mouse and horse from virus challenge and expresses in vitro a noninfectious recombinant antigen that can be used in enzyme-linked immunosorbent assays","volume":"75","author":"Davis","year":"2001","journal-title":"J. Virol."},{"key":"2025032411163649500_r42","doi-asserted-by":"crossref","first-page":"809","DOI":"10.1086\/323395","article-title":"Induction of potent Th1-type immune responses from a novel DNA vaccine for West Nile virus New York isolate (WNV-NY1999)","volume":"184","author":"Yang","year":"2001","journal-title":"J. Infect. Dis."},{"key":"2025032411163649500_r43","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.micinf.2006.09.009","article-title":"The envelope glycoprotein domain III of dengue virus serotypes 1 and 2 inhibit virus entry","volume":"9","author":"Chin","year":"2007","journal-title":"Microbes Infect."},{"key":"2025032411163649500_r44","doi-asserted-by":"crossref","first-page":"1392","DOI":"10.3201\/eid0812.020229","article-title":"Efficacy of killed virus vaccine, live attenuated chimeric virus vaccine, and passive immunization for prevention of West Nile virus encephalitis in hamster model","volume":"8","author":"Tesh","year":"2002","journal-title":"Emerg. Infect. Dis."},{"key":"2025032411163649500_r45","doi-asserted-by":"crossref","first-page":"12497","DOI":"10.1128\/JVI.78.22.12497-12507.2004","article-title":"ChimeriVax-West Nile virus live-attenuated vaccine: preclinical evaluation of safety, immunogenicity, and efficacy","volume":"78","author":"Arroyo","year":"2004","journal-title":"J. Virol."},{"key":"2025032411163649500_r46","doi-asserted-by":"crossref","first-page":"2578","DOI":"10.1128\/JVI.77.4.2578-2586.2003","article-title":"B cells and antibody play critical roles in the immediate defense of disseminated infection by West Nile encephalitis virus","volume":"77","author":"Diamond","year":"2003","journal-title":"J. Virol."},{"key":"2025032411163649500_r47","doi-asserted-by":"crossref","first-page":"2524","DOI":"10.4049\/jimmunol.171.5.2524","article-title":"IFN-gamma-producing gamma delta T cells help control murine West Nile virus infection","volume":"171","author":"Wang","year":"2003","journal-title":"J. Immunol."},{"key":"2025032411163649500_r48","doi-asserted-by":"crossref","first-page":"8312","DOI":"10.1128\/JVI.78.15.8312-8321.2004","article-title":"Role of CD8+ T cells in control of West Nile virus infection","volume":"78","author":"Shrestha","year":"2004","journal-title":"J. Virol."},{"key":"2025032411163649500_r49","doi-asserted-by":"crossref","first-page":"12060","DOI":"10.1128\/JVI.01650-06","article-title":"CD4+ T-cell responses are required for clearance of West Nile virus from the central nervous system","volume":"80","author":"Sitati","year":"2006","journal-title":"J. Virol."}],"container-title":["The Journal of Immunology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/academic.oup.com\/jimmunol\/article-pdf\/186\/7\/3882\/62476448\/1002799.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/jimmunol\/article-pdf\/186\/7\/3882\/62476448\/1002799.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,3,28]],"date-time":"2025-03-28T13:23:45Z","timestamp":1743168225000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/jimmunol\/article\/186\/7\/3882\/7990102"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2011,4,1]]},"references-count":49,"journal-issue":{"issue":"7","published-print":{"date-parts":[[2011,4,1]]}},"URL":"https:\/\/doi.org\/10.4049\/jimmunol.1002799","relation":{},"ISSN":["0022-1767","1550-6606"],"issn-type":[{"value":"0022-1767","type":"print"},{"value":"1550-6606","type":"electronic"}],"subject":[],"published-other":{"date-parts":[[2011,4]]},"published":{"date-parts":[[2011,4,1]]}}}